Method of treating HIV infection

Details Method of treating HIV infection Method of treating HIV infection

1994-04-15

1996-09-10

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514114, A61K 3113

Patent

active

055546552

ABSTRACT:
Cysteamine, cystamine, and phosphocysteamine are effective agents for the treatment of HIV infections.

REFERENCES:
patent: 3892824 (1975-07-01), Piper et al.
patent: 3991190 (1976-11-01), Garzia et al.
Merck Index 10th ed. #2771 & 2773.
Oxford 78CA: 119655t 1973.
Hotz 81CA: 101420q 1974.
Schroeder et al. 110CA: 18156e 1989.
Pisoni et al, J. Bio. Chem., vol. 260, No. 8, pp. 4791-4798, (1985).
Thoene et al, J. of Ped., vol. 96, No. 6, pp. 1043-1044, (1980).
Thoene et al, J. Clin. Invest., vol. 58, pp. 180-189, (1976).
Ca 78: 119655t 1973.
CA 85:28782k 1976.
CA 113: 55076m 1990.
CA 112: 48337y 1990.
CA 117: 258256a 1992.
Windholtz, "The Merck Index", 10th edition, published 1983 by Merck & Co., Inc. items 2773, 2775 and 2776 1983.
CA 107: 108862z 1987.
CA 84: 155677j 1976.
CA 75: 85659t 1971 1971.
Ryser et al, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 4559-4563 (1994).
Bergamini et al, J. Clin. Invest., vol. 93, pp. 2251-2257 (1994).
The Journal of Clinical Investigation, (1994), 93, pp. 2251-2257, "Cystamine Potently Suppresses in Vitro HIV Replication in Acutely and Chronically Infected human Cells", A. Bergamini et al.
Clinically Research, (1992), 40, p. 264A, "In-Vitro Effectiveness of Aminothiols And Disulfides Against HIV-1'", J. Thoene.
NATO ASI SER., (1986), 120, pp. 329-342, "Inhibition Of HTLV-III Replication In Cell Cultures", P.S. Sarin et al.
Proc. Natl. Acad. Sci., (1991), 88, pp. 986-990, "Suppression of Human Immunodeficiency Virus Expression in Chronicallly Infected Monocytic Cells By Glutathione, Glutathione Ester, And N-Acetylcysteine", Kalebic et al.
Carinogenesis, (1991), 12, pp. 241-247, "Modulation of Glutathoine Content and the effect on Methionine Auxotrophy and Cellular Distribution of Homocysteine and Cysteine in Mouse Cell Lines", Djurhuus et al.
Arzneimittel Forschung, (1986), 36, pp. 1531-1534, "Treatment of HTLV-III /LAV-Infected Patients with D-Penicillamine", R. Schulof et al.
Aids Research And Human Retroviruses, (1990), 6, pp.919-927, "2,3 Dimercapto-1-Propanol Inhibits HIV-1 tat Activity, Viral Production, and Infectivity In Vitro", S. Kubota et al.
Fields Virology, 2nd Ed., B. N. Fields, et al. Eds., Raven Press, NY, vol. 1, pp. 1075-1089 (1990).
Fields Virology, 2nd Ed. B. N. Fields, et al. Eds. Raven Press, NY, vol. 2, pp. 1437-1440, 1452-1477, (1990).
Fields Virology, 2nd Ed. B. N. Fields, et al. Eds. Raven Press, NY, vol. 1, pp. 507-548 (1990).
Fields Virology, 2nd Ed. B. N. Fields, et al. Eds., Raven Press, NY, vol. 2, pp. 1787-1790 (1990).
Fields Virology, 2nd Ed. B. N. Fields, et al. Eds. Raven Press, NY, vol. 2, pp. 1529-1543, (1990).
Dagani, C&EN, Nov. 23, 1987, pp. 41-49.
Droge et al, Am. J. Med., vol. 91, pp. 140S-144S , (1991).
Mihm et al, AIDS, vol. 5, pp. 497-503 (1991).
Perrin et al, Pharmac. Ther., vol. 12, pp. 255-297 (1981).
Pompei et al, Experientia, vol. 33, pp. 1151-1152 (1977).
La Colla et al, Ann. NY Acad. Sci. vol. 284, pp. 294-304 (1977).
La Colla et al, Experientia, vol. 31, pp. 797-798, (1975).
Marcialis et al, Experientia, vol. 29, pp. 1559-1661 (1973).
Schivo et al, Experientia, vol. 32, pp. 911-913 (1976).
Billard et al, Antimicrobial Agents and Chemotherapy, vol. 5, pp. 19-24 (1974).
M. S. Marcialis et al, Experientia, vol. 30, pp. 1272-1273 (1974).
Staal et al, The Lancet, vol. 339, pp. 909-912 (1992).
Roederer et al, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 4884-4888, (1990).
Oxford et al, J. Gen. Virol., vol. 18, pp. 11-19 (1973).
Oxford et al, Ann. NY Acad., vol. 284, pp. 613-623 (1977).
Arora et al, Can. J. Biochem., vol. 58, pp. 67-72 919800.
Gliniak et al, J. Bio. Chem., vol. 266, No. 34, pp. 22991-22997, (1991).
Leonard et al, J. Bio. Chem., vol. 265, No. 18, pp. 10373-10382, (1990).
Lekutis et al, J. Acq. Imm. Def. Syn., vol. 5, pp. 78-81, (1992).
Papadopolus-Eleopulos et al, The Lancet, vol. 338, pp. 1013-1014, (1991).
Cardin et al, J. Biol. Chem., vol. 266, No. 20, pp. 13355-13363, (1991). (Abstract).
Kim et al, Biochem. Biophys. Res. Comm., vol. 179, No. 3, pp. 1614-1619, (1991).
Gahl et al, New Engl. J. Med., vol. 316, pp. 971-977, (1987).
Wilson et al, J. Am. Chem. Soc., vol. 102, pp. 359-363, (1980).
Smolin et al, Ped. Res., vol. 23, No. 6, pp. 616-620, (1988).
Owens et al, Virology, vol. 179, pp. 827-833, (1990).
Willey et al, Proc. Natl. Aca. Sci. USA, vol. 85, pp. 9580-9584, (1988).
Dedera et al, J. Vir., vol. 65, No. 11, pp. 6129-6136, (1991).
Harakeh et al, Am. Clin. Nutr., vol. 54, pp. 1231S-1235S, (1991).
Bacq, Chemical Protection Against Ionizing Radiation, IV, "The Protective Compounds", pp. 16-35., Charles C. Thomas, USA.
Thoene, "Orphan Drugs and Orphan Diseases: Clinical Realities and Public Policy," pp. 125-131, Alan R. Liss, Inc., NY, 1983.
Thoene, "Cooperative Approaches to Res. and Dev. of Orphan Drugs", pp. 157-162, Alan R. Liss, Inc., 1985.
Turner, Med. J. Austral., vol. 153, pp. 502, (1990).

Affiliated with

Also associated with

Rating

Method of treating HIV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating HIV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating HIV infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1320953